Context Therapeutics Inc. · NASDAQ:CNTX
Context Therapeutics Inc. shareholders
As of Sep 30, 2026, 83 institutions reported holding Context Therapeutics Inc., 63.9% of its shares. Largest: Deep Track Capital, LP, Nextech Invest Ltd. and Soleus Capital Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Context Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| Deep Track Capital, LP | 7.42M | 8.1% | no change | Nov 16, 2026 |
| Nextech Invest Ltd. | 7.42M | 8.1% | no change | Nov 16, 2026 |
| Soleus Capital Management, L.P. | 7.06M | 7.7% | no change | Nov 16, 2026 |
| BlackRock | 6.14M | 6.7% | −29,984 | Nov 13, 2026 |
| Vanguard | 4.52M | 4.9% | +6,866 | Nov 16, 2026 |
| Avidity Partners Management LP | 4.06M | 4.4% | −938K | Nov 16, 2026 |
| AQR Capital Management LLC | 2.93M | 3.2% | new | Nov 16, 2026 |
| TCG Crossover Management, LLC | 2.68M | 2.9% | no change | Nov 16, 2026 |
| Acadian Asset Management LLC | 1.99M | 2.2% | +980K | Nov 9, 2026 |
| Geode Capital | 1.9M | 2.1% | +65,160 | Nov 6, 2026 |